gastric-cancer

Documents about gastric-cancer

• A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer#879634ClinicalTrials.gov
• "Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer" (THERRES)#904512ClinicalTrials.gov
• Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial#981753ClinicalTrials.gov
• The Relationship Between Time Perspective, Fear of Cancer Recurrence, Rumination, and Catastrophizing in Gastric Cancer Survivors#827487ClinicalTrials.gov
• Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study#883709ClinicalTrials.gov
• Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases#981532ClinicalTrials.gov
• Temporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gastric Cancer Survivors#842757ClinicalTrials.gov
• Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma#127612ClinicalTrials.gov
• Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus#888857ClinicalTrials.gov
• Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer#832175ClinicalTrials.gov
• Fruquintinib Combined With TAS102 for Advanced Gastric Cancer#840442ClinicalTrials.gov
• Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer#885143ClinicalTrials.gov
• Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer#902647ClinicalTrials.gov
• Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.#143569ClinicalTrials.gov
• Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer#272365ClinicalTrials.gov
• Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)#683083ClinicalTrials.gov
• FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer#848768ClinicalTrials.gov
• Prediction of Benefit From Adjuvant Chemotherapy for pT1N1 Gastric Cancer#850937ClinicalTrials.gov
• Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer#862929ClinicalTrials.gov
• Apatinib for the Elderly Advanced Gastric Cancer#870725ClinicalTrials.gov
• Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer#874492ClinicalTrials.gov
• Swedish Oesophago-Gastric Study#967227ClinicalTrials.gov
• Perioperative Chemo and Pembrolizumab in Gastric Cancer#841088ClinicalTrials.gov
• Laparoscopic Gastric Function Preserving Surgery Combined With Resection of the Anterior Lymphatic Drainage Area#889088ClinicalTrials.gov
• Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin#828894ClinicalTrials.gov
• Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach#888725ClinicalTrials.gov
• Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer#916682ClinicalTrials.gov
• Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer#806157ClinicalTrials.gov
• Prehabilitation Plus ERAS in Gastric Cancer Surgery#858398ClinicalTrials.gov
• Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer#876649ClinicalTrials.gov
• QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer#993542ClinicalTrials.gov
• A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer#995132ClinicalTrials.gov
• A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)#803249ClinicalTrials.gov
• Gene Therapy in Treating Patients With Cancer#901580ClinicalTrials.gov
• Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer#843020ClinicalTrials.gov
• Quality of Life After Oesophageal or Gastric Cancer Surgery#859808ClinicalTrials.gov
• Phase II Study for Robot Assisted Distal Gastrectomy#836286ClinicalTrials.gov
• Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer#874197ClinicalTrials.gov
• Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer#839837ClinicalTrials.gov
• D1 Versus D2 Lymphadenectomy in High Risk Elderly With Gastric Adenocarcinoma#867292ClinicalTrials.gov
• Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer#801200ClinicalTrials.gov
• Energy CT in Imaging and Diagnosis of Gastric Cancer#812295ClinicalTrials.gov
• Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.#813314ClinicalTrials.gov
• Confocal Laser Endomicroscopy for in Vivo Molecular Imaging of Gastric Cancer by Targeting MG7-Ag#868365ClinicalTrials.gov
• The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular Profiling#896620ClinicalTrials.gov
• Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer#905127ClinicalTrials.gov
• Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer#969187ClinicalTrials.gov
• Comprehensive in‑silico molecular analysis of early‑onset gastric cancer identifies novel genes implicated in disease characterization and progression (Review)#439805Repositorio Universidad del Desarrollo
• Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology#827252ClinicalTrials.gov
• A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer#991659ClinicalTrials.gov